drugset / Trial / NCT00649116

Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mg

NCT00649116

Phase 1 Completed 20 enrolled Mylan Pharmaceuticals Inc
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study was to investigate the bioequivalence of Mylan's metoprolol tartrate tablets to Novartis's Lopressor® tablets following a single, oral 100 mg (1 x 100 mg) dose administered under fed conditions.

Timeline

Start
2002-12
Primary completion
2002-12
Completion
2003-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoprolol Other / unclassified 100 mg Oral

Indications

No indication recorded.